Gilead lawsuit settlements Jul 15, 2025 · Attorney General William Tong today joined a coalition of 48 other attorneys general in securing $202 million from Gilead Sciences, Inc. Gilead Sciences, Inc. For legal practitioners dealing with Truvada injury lawsuits, medical records are central to […] May 5, 2025 · Gilead Sciences has agreed to pay $202 million to resolve allegations of paying kickbacks to doctors for prescribing its HIV drugs, and separately settled a high-profile patent dispute with the U. government to resolve the feds’ last-ditch appeal of a case which involved the patents on Gilead’s HIV drugs. Jul 15, 2025 · Pennsylvania Will Receive $1. Jul 15, 2025 · $202M Settlement Approved: 49 Attorneys General Strike Deal With Gilead "Government health care dollars are precious and must be used without favor in order to achieve the highest possible health Jun 13, 2024 · Recall that AIDS Healthcare Foundation (AHF) called upon Gilead to set up a $10 billion fund in anticipation of massive settlements in the class action lawsuit. , seeking compensation for the losses sustained by victims of their drugs' side effects. Gilead violated federal law by illegally providing incentives – including awards, […] Jul 15, 2025 · Pennsylvania Will Receive $1. The unlawful scheme View Article Apr 29, 2025 · Investing. V. Squibb & Sons, L. Aug 1, 2025 · An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent rights to HIV prevention pills Attorney General Jeff Jackson announced that Gilead Sciences will pay $202 million to resolve claims it paid in kickbacks. Mar 4, 2025 · Gilead Sciences sets aside $200 million for a potential settlement over its HIV drug promotional speaker program amid federal investigation. The lawsuits claim that the warning labels on TDF drugs failed to warn doctors and patients of Apr 29, 2025 · The settlement, which calls for Gilead to pay the U. The Jul 17, 2025 · Jul. 3 days ago · Deborah Telman, Gilead Sciences Inc. Many of these Truvada cases are pending in court. Stribild contains the drug TDF, which can cause serious side effects such as kidney failure and bone fractures as well as lactic acidosis. While the recent federal settlement marks a significant step, many cases remain unresolved, particularly in the California state courts. , engaged in a variety of allegedly anticompetitive conduct that caused certain consumers and third-party payors to pay too much for HIV medicines, specifically: Atripla, Biktarvy, Complera, Descovy Filing an HIV drug lawsuit? Learn more about Viread, Truvada, kidney failure, bone damage, and more. , focusing on the harmful side effects caused by the drug Truvada, used in the treatment of HIV. Oct 25, 2019 · HIV patients who take medication made by the pharmaceutical company Gilead and have suffered severe side effects may be eligible to file a Gilead lawsuit. 8 million antitrust class action lawsuit settlement with direct purchasers of its HIV medications. Truvada is an antiretroviral drug used in the prevention or management of HIV infections. Nov 10, 2021 · Gilead Sciences, Bristol-Myers Squibb, Janssen Pharmaceuticals and a group of consumers who accused the companies of conspiring to keep certain HIV therapy drugs off the market and at high prices have reached a $10 million class action settlement. Now, that settlement is moving ahead. 28 will be paid to the U. Moreover, there is growing evidence that Current Status of Truvada Lawsuit Settlements At this stage, there have been no settlements reached at this point in the Gilead Sciences lawsuits. Per the terms of the settlement, Gilead will pay $246. In their lawsuit, plaintiffs who took TDF and suffered skeletal or kidney damage said that Gilead’s decision to discontinue work on TAF was driven by a conscious business strategy to maximize the financial value of the less effective, more problematic TDF. Here are the key developments from June to August 2023: Discover how Gilead Sciences paid $202 million to settle serious healthcare fraud violations involving kickbacks to doctors prescribing HIV medications. government over Truvada and Descovy for HIV prevention. A $10 Million lawsuit has been settlement involving large pharmaceutical companies Bristol-Myers Squibb and Gilead on behalf of defendants. The lawsuit involves the alleged delay of generic competition for certain HIV cART drugs and the prices paid for those drugs. Sep 26, 2023 · After that trial result, KPH Health Services pursued a class-action settlement with Gilead on behalf of drug purchasers, according to Courthouse News Service. It has been the center of many controversies lately. Jul 15, 2025 · Settlement Agreement TRENTON — Attorney General Matthew J. Generally, however, large groups of settlements do not occur until such time as a few lawsuits are tried before a jury, and the manufacturer is able to more thoroughly understand its financial risk. nearly $177 million and the balance to various states, was approved Monday in U. D. However, there may be some plaintiffs in the federal TDF litigation who do not elect to participate in the settlement and there are others who are not part of this agreement. Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy. As is often the case, both results are cautionary tales: first, because they included damages and penalties totaling hundreds of millions of dollars; and second Discover top Truvada lawsuit lawyers now! Gain insights into settlements, side effects, and seeking compensation. However, because the Truvada lawsuits are still very new, settlements are still a long way away. ), coordinated with In re HIV Antitrust Litigation (formerly called Staley v. Truvada and TDF lawsuits have been filed against Gilead Sciences, Inc. 6 billion in damages. The resolution settles a near decade-long qui tam lawsuit filed by a whistleblower who was an insider physician with firsthand knowledge of Gilead’s internal practices. Gilead paid many high-volume prescribers of HIV drugs tens or hundreds of thousands of dollars in honoraria to prepare and present as HIV Speakers. Apr 29, 2025 · Investing. RECITALS A. Oct 15, 2024 · The majority of TDF lawsuits against Gilead were being filed in the Northern District of California including the earliest cases, which is where Gilead is located. Nov 11, 2025 · A typical Truvada lawsuit includes allegations that the manufacturer failed to adequately warn about the dangers of the drug and many people are left living with bone problems, kidney damage, and other conditions. Jan 16, 2024 · Gilead stopped development of TAF in 2004. , Gilead Holdings, LLC, Gilead Sciences, LLC, and Gilead Sciences Ireland UC ("Gilead Jun 11, 2024 · As Gilead Sciences awaits the progression of California state litigation over its alleged delay of safer HIV drugs, the company is biding its time with a proposed $40 million settlement to quell Sep 25, 2023 · U. Engelmayer, GILEAD agreed to pay a total sum of $202 million, of which $176,927,889. A landmark whistleblower case. Under the terms of the agreement, Gilead will pay $202 million. Truvada Lawsuits and Settlements Like any pharmaceutical company, Gilead is duty-bound to warn consumers about any health risks connected with their drugs. 75 million class action settlement between Gilead Sciences and KPH Health Services over allegations that Gilead used anticompetitive practices to slow the process of getting generic HIV drugs to market. May 6, 2025 · The SDNY’s recent civil False Claims Act settlement with Gilead over the company’s speaker programs underscores the importance of strong compliance measures and proactive monitoring for life sciences companies to prevent similar enforcement actions. A Stribild lawsuit is a mass tort claim against Gilead Sciences, Inc. The majority of individual injury cases are pending in California, and the Jul 5, 2023 · Gilead and Teva were accused of conspiring to keep HIV generics off the market in a 2019 lawsuit seeking $3. , No. Apr 29, 2025 · NEW YORK (Reuters) -Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying kickbacks to doctors who agreed to prescribe its Dec 9, 2024 · A tentative Truvada settlements deal has been announced to partially resolve a class action on HIV medication lawsuit settlement over allegedly expensive HIV drugs as a result of anti-competitive practices by Gilead and several other major antiretroviral pill makers. Jun 4, 2024 · In 2001, Gilead was also developing another HIV drug, tenofovir alafenamide fumarate, or TAF. Read more here. The litigation Sep 23, 2020 · Pharmaceutical company Gilead Sciences, Inc. 's top lawyer for the past three years, is relinquishing her duties as general counsel and head of corporate affairs effective Dec. District Court for the Southern District of New York, resolves allegations that Gilead violated federal May 1, 2025 · New York: Gilead Sciences has agreed to pay USD 202 million to settle a whistleblower lawsuit that accused the company of engaging in civil fraud by providing illegal kickbacks to doctors in A lawsuit (“the lawsuit”) is pending in the United States District Court for the Northern District of California (“the Court”) against the following Defendants: Gilead Sciences, Inc. The talk of the town is the national Truvada class action suit against Gilead. Jul 17, 2025 · Foster City pharmaceuticals giant Gilead Sciences has agreed to pay a $202 million settlement over allegations in a lawsuit by state and federal authorities that it paid doctors kickbacks, sent Jan 22, 2025 · HIV drugmaker Gilead Sciences and the U. Platkin and the Office of the Insurance Fraud Prosecutor (OIFP) announced New Jersey has joined a coalition of 48 other attorneys general in securing $202 million from Gilead Sciences, Inc. Jul 15, 2025 · Attorney General James Secures Over $200 Million from Gilead Sciences for Paying Illegal Kickbacks AG James Leads Coalition Stopping Gilead’s Illegal Scheme to Promote HIV Medication New York Will Receive $6. As such, it makes it difficult to predict the average Truvada lawsuit settlement as cases in California and around the United States continue to develop. District Judge Paul A. | Gilead set aside approximately $200 million for a potential resolution of an eight-year case surrounding its promotional speaker Jul 15, 2025 · In doing so, Gilead violated the federal Anti-Kickback Statute and caused providers to submit false claims for Gilead HIV drugs that were the result of these kickbacks to the state’s Medicaid programs. law. over its HIV medications. Guide to lawsuits and claims filed against Gilead Sciences. Oct 9, 2018 · Another Gilead lawsuit from California plaintiffs living with HIV has similar allegations over bone and kidney damage from TDF drugs. This Gilead lawsuit was filed as a class action, and funded by the AIDS Healthcare Foundation (AHF). 5. The settlement, which calls for Gilead to pay the U. and its supplier MSN Laboratories Pvt. Jan 29, 2025 · Truvada lawsuit settlements haven't been reached as of February 2025, with over 26,000 plaintiffs still engaged in legal action against Gilead Sciences. over billions in profits tied to HIV drug patents, arguing the deal shortchanges taxpayers and sets a troubling precedent for government-funded innovation. 8. )). Apr 5, 2023 · Gilead Sciences designed its HIV drugs to contain a form of tenofovir the company “knew was toxic to patients’ kidneys and bones,” a lawsuit alleges. and Gilead have reached a settlement agreement involving patent rights to two HIV drugs, Truvada and Descovy, which are used as pre-exposure prophylaxis treatments to prevent the spread Settlements of TDF lawsuits are likely to resolve the mass tort claims against Gilead Sciences, Inc. C. Jun 4, 2024 · Gilead expects that the settlement will resolve the claims of the overwhelming majority of plaintiffs in the federal TDF litigation. Major ongoing cases against Gilead Sciences concerning the health risks linked with Truvada include: Christopher Pierot v. As part of the settlement, Gilead made extensive factual admissions regarding its conduct. These lawsuits primarily center on allegations of illegal kickbacks to healthcare providers, delayed development of safer drug versions, and product liability claims related to side effects of older HIV medications. over their Symtuza copies, according to court filings. Jun 4, 2019 · Patients seeking Gilead lawsuit settlements claim the company has made anticompetitive deals to monopolize the HIV drug market at the cost of patients. Gilead has agreed to pay $202 million – split between the federal and state Apr 18, 2024 · Truvada Lawsuit The Truvada lawsuit addresses serious allegations against Gilead Sciences, Inc. Adrian Holley, et al. These side effects can include bone loss and osteoporosis, kidney failure, and lactic acidosis. Senior District Judge Edward Chen, having assessed the fairness, reasonableness and adequacy of the settlement, handed down preliminary approval on Monday. Oct 9, 2023 · Under the Settlement, Gilead will pay $246,750,000 into a Settlement Fund to settle all claims in the lawsuit. 3:20-cv-06961-EMC (N. agreed to pay $202 million to resolve civil allegations under The False Claims Act (FCA) and the Anti-Kickback Statute (AKS) in April 2025. The lawsuit claims that Gilead Sciences, Inc. May 21, 2020 · Final Approval of $4 Million Settlement in Gilead Class Action Lawsuit An Alabama man was mortified when an envelope for him turned up in his workplace mailroom with the return address HIV Prevention Team in bold red lettering. Jun 11, 2024 · HIV drugmaker Gilead Sciences has agreed to pay up to $40 million in a one-time payment to settle a lawsuit involving its HIV med Viread (tenofovir disoproxil fumarate, or TDF), a component of several treatment regimens. (Gilead), based in Foster City, California, has agreed to pay $97 million to resolve claims that it violated the False Claims Act by illegally using a foundation as a conduit to pay the copays of thousands of Medicare patients taking Gilead’s pulmonary arterial hypertension drug, Letairis, the Justice Department announced today. May 1, 2025 · Here are 10 recent healthcare industry lawsuits, settlements and legal developments that Becker's has reported since April 22: Jan 15, 2025 · After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a pair of HIV prevention pills. Aug 23, 2023 · Gilead Sciences reached a $246. However, the good news is that Tribeca Lawsuit Loans can provide you with pre-settlement legal funding Jan 21, 2025 · 7. 28 Million from Multistate Settlement HARRISBURG – Attorney General Dave Sunday joined a coalition of 48 other Attorneys General in securing a combined $202 million settlement from Gilead Sciences, Inc. for running an illegal kickback scheme to promote its HIV medications. Jul 16, 2025 · Oregon to Receive Over $467,000 in Restitution and Penalties Attorney General Dan Rayfield announced today that Oregon has joined a multistate coalition in securing a $202 million settlement in principle with Gilead Sciences, Inc. Apr 29, 2025 · Under the settlement, which was approved yesterday by U. May 2, 2024 · California’s top court agreed Wednesday to consider the viability of a groundbreaking liability theory used by thousands of plaintiffs against Gilead Sciences Inc. Jan 15, 2025 · The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. over its proposed generic versions of HIV treatments Symtuza and Genvoya and with Lupin Ltd. Apr 29, 2025 · The settlement resolves claims that GILEAD offered and paid kickbacks in the form of honoraria payments, meals, and travel expenses to healthcare practitioners who spoke at or attended Gilead speaker events to induce them to prescribe Stribild ®, Genvoya ®, Complera ®, Odefsey ®, Descovy ®, and Biktarvy ® (the “Gilead HIV Drugs”) in Jan 15, 2025 · “Today’s settlement ends this litigation, and this final resolution allows Gilead to continue to focus its resources on its mission to discover, develop, and deliver innovative therapeutics to people with life-threatening diseases. TDF litigation could have widespread negative consequences for pharmaceutical development and broader manufacturing innovation beyond the state of California. The lawsuit alleges that Gilead engaged in a variety of allegedly anticompetitive Apr 29, 2025 · Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that they paid kickbacks to boost sales. (“BMS”), and Johnson & Johnson, Janssen Products Oct 20, 2025 · The lawsuit filed against Truvada manufacturer Gilead Sciences, Inc. Department of Justice and approved by the U. Gilead Truvada Settlements Amounts Currently, no settlements have been reached in the Truvada lawsuits. . ), No. Gilead violated federal law by illegally providing incentives – including awards, […] Sep 23, 2020 · "the Parties"), through their authorized representatives. Sep 10, 2019 · According to a recent lawsuit filed against Gilead, the company may have concealed information about tenofovir adverse effects. v. The legal Jan 15, 2025 · By Blake Brittain (Reuters) – Gilead Sciences and the U. ("Gilead"), is a Delaware corporation with principal executive offices located in Foster City, California. The litigation Jan 16, 2025 · Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy. , resolving allegations that the pharmaceutical giant paid illegal kickbacks to health care providers to promote its HIV medications. government have settled a billion-dollar patent dispute over Gilead’s HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. Ltd. Attorney's Office for the Southern District of New York revealed that Gilead will pay nearly $177 million to the U. Feb 18, 2025 · Gilead Sciences Inc. Those seeking compensation for injuries caused by the Gilead HIV drugs, either in the Northern District of California class action or an individual lawsuit, still have a ways to go before settlements are reached. In addition, they claim that Gilead withheld a safer alternative, tenofovir alafenamide, or TAF, in order to maximize profits from Truvada. The company halted its work in 2004, saying TAF was essentially the same as TDF. There may also be lawsuits against Gilead Sciences filed by family members of those who died from conditions allegedly caused by taking Truvada. Current Status of Truvada Lawsuit Settlements At this stage, there have been no settlements reached at this point in the Gilead Sciences lawsuits. The kickback settlement ends a whistleblower lawsuit alleging Gilead paid doctors through lavish speaker programs, meals, and travel to boost Jan 21, 2025 · Public health advocates expressed outrage at the US government’s settlement of its lawsuit against Gilead Sciences Inc. Jun 16, 2025 · Pharmaceutical manufacturer Gilead Sciences, Inc. Jul 17, 2025 · The settlement—which was handled on behalf of Delaware by AG Jennings’ Medicaid Fraud Control Unit—will resolve allegations that from January 2011 through November 2017, Gilead made payments, provided meals, and paid travel expenses to healthcare practitioners who spoke at or attended Gilead speaker events. 6 Million from Multistate Settlement in Principle Oct 30, 2025 · Truvada (emtricitabine and tenofovir disoproxil fumarate) lawsuits claim that the drug causes kidney problems and bone loss. Gilead paid approximately 60 healthcare providers involved in the treatment of HIV over $100,000 each in total honorarium payments, in addition to paying for their meals and any travel expenses, and the vast majority of these individuals prescribed The Gilead lawsuit refers to a series of high-profile legal cases involving Gilead Sciences, a leading pharmaceutical company known for its HIV and antiviral drugs. Nov 1, 2025 · TDF Truvada Lawsuit Update 2024-2025 Since May 2018, thousands TDF drug users have filed Truvada lawsuits over the injuries they experienced. However, Gilead failed to warn people about these risks on the TDF drug's warning label. Individuals who have opted-out of the class-action suit and pursued a civil lawsuit in their state of residence have yet to publicly-disclose the awards they have received, if any. These payments and gifts induced the healthcare practitioners to prescribe the Sep 10, 2019 · According to a recent lawsuit filed against Gilead, the company may have concealed information about tenofovir adverse effects. As we delve deeper into the legal proceedings, it's evident that the complexities and sheer volume of cases have made this one of the most closely observed pharmaceutical litigations in recent history. , the HIV medication's manufacturer. The Oct 13, 2023 · Gilead agreed to a settlement to resolve class action lawsuit claims it made buyers of HIV medicine such as Truvada and Atripla HIV overpay. and Johnson & Johnson’s Janssen unit settled lawsuits with Apotex Inc. District Court in Manhattan by Judge Paul Engelmayer. This occurred after HIV positive California residents filed a personal injury lawsuit against Gilead, arguing that the company had withheld safer HIV medications but continued to promote Viread instead. over an illegal kickback scheme to The settlement, coordinated with the U. Pharmaceutical firm Gilead has admitted paying hundreds of thousands of dollars in illegal kickbacks to US doctors between January 2011 and November 2017, as inducements for prescribing the company’s HIV drugs. Aug 22, 2022 · Gilead Sciences Inc must face a proposed class action lawsuit accusing it of paying off Indian generic drugmaker Cipla Ltd not to compete with its HIV preventive drug Truvada, a federal judge has Jun 28, 2022 · Gilead Sciences is making serious headway on prosecuting Florida clinics that exploited its access program for HIV prevention drugs. was filed in May 2019 in the Northern District of California. Jan 20, 2025 · The U. Ongoing lawsuits against Truvada’s manufacturer Gilead allege that the company’s drug caused severe bone and kidney damage to many patients. L. 17—Foster City pharmaceuticals giant Gilead Sciences has agreed to pay a $202 million settlement over allegations in a lawsuit by state and federal authorities that it paid doctors Jan 15, 2025 · Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and Descovy. According to the settlement papers Nov 16, 2023 · Truvada lawsuits claim that the pre-exposure prophylaxis, or PrEP, drug causes bone loss and kidney problems that the drug’s maker, Gilead Sciences, did not warn the public about. , Gilead Holdings, LLC, Gilead Sciences, LLC, and Gilead Sciences Ireland UC (“Gilead”), Bristol-Myers Squibb Company and E. What Are the Expected Truvada Lawsuit Settlement Amounts When getting into the nitty-gritty of Truvada lawsuits, there’s a lot to keep in mind. Oct 3, 2024 · The summer months of 2023 have proven to be a whirlwind of activity in the ongoing Truvada lawsuit against Gilead Sciences Inc. Attorney’s Office for the Southern District of New York last week announced the resolution of two significant False Claims Act (FCA) cases—one from a large settlement and the other the result of a jury verdict after trial. government—and about $25 million to Oct 4, 2023 · SAN FRANCISCO (CN) — A federal judge on Monday gave preliminary approval to a $246. Jul 23, 2025 · RALEIGH – Attorney General Jeff Jackson announced that Gilead Sciences will pay $202 million to resolve claims that it paid kickbacks to doctors in exchange for promoting its HIV medications, resulting in millions of dollars of false claims submitted to government health care programs, including North Carolina’s Medicaid program. In the latest twist, the company inked a $33 million settlement Jul 16, 2025 · In the settlement, Gilead acknowledged using an “HIV Speaker” program to funnel rewards to high-volume prescribers over seven years between 2011 to 2017. Jan 15, 2025 · Gilead Sciences and the U. The company paid between tens and May 7, 2025 · The U. Seek Ethen Ostroff Law's legal guidance. The bulk of the group’s argument hinges on Gilead’s early testing on TAF Jul 15, 2025 · Gilead Sciences (GILD) stock slips as the company agrees to pay $202M to settle allegations that its HIV drug promotion program violated U. Gilead’s HIV speaker programs have served to educate healthcare professionals about the appropriate use and benefits of these important medicines. Apr 29, 2025 · Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying kickbacks to doctors who agreed to prescribe its HIV drugs. Jan 12, 2024 · After several separate lawsuits were filed, around 24,000 TDF users joined in on legal action against the company. This ongoing legal Jul 15, 2025 · Attorney General William Tong today joined a coalition of 48 other attorneys general in securing $202 million from Gilead Sciences, Inc. 75 million into a settlement fund to benefit the certified class of direct customers. What Is the Average Truvada Lawsuit Settlement? Currently, no Truvada lawsuit case has reached a settlement or verdict yet, so cases are still ongoing. But the lawsuit said If you have kidney or bone loss issues from the HIV drug Truvada, you may be entitled to compensation. com -- Gilead Sciences (NASDAQ: GILD), a leading American biopharmaceutical company, has agreed to pay a $202 million settlement to resolve a civil fraud lawsuit. Potential settlement amounts and class action lawsuit news and update on TDF HIV drug lawsuits. Even though it has benefitted so many in fighting HIV, its side effects have raised a lot of eyebrows. What Is the Average Truvada Lawsuit Settlement? The pending class-action lawsuit against Gilead Sciences, Inc. Apr 29, 2025 · A New York doctor who treated HIV and AIDS patients sued Gilead for violating the False Claims Act with payments to doctors who spoke at sponsored events. Lawsuits allege that Gilead Sciences manufactured a less toxic version of the drug, but withheld it from the market. ), coordinated with Staley v. A proposed settlement (“Settlement”) has been reached in a class action lawsuit (KPH Healthcare Services, Inc. Gilead General Counsel […] Apr 18, 2019 · The Superior Court judge presiding over the Gilead Viread medication lawsuit rejected requests from the defendant to dismiss the claims. Apr 6, 2022 · THE DEADLINE TO FILE A CLAIM HAS PASSED. The drug—tenofovir alafenamide fumarate (TAF), present in Odefsey, Genvoya, Descovy, Biktarvy, and Vemlidy—was allegedly tested in clinical trials in 2002, but wasn’t released until 2015. Gilead could disturb the model of public-private partnership that sustains many of the United States’ most important medical breakthroughs. Apr 26, 2024 · Updates on the status of the many ongoing Truvada lawsuits brought by more than 26,000 plaintiffs against Gilead Sciences. A partial settlement has been reached in a class action lawsuit involving the antiretroviral drugs Atripla, Biktarvy, Complera, Descovy, Evotazz, Odefsey, Prezcobix, Stribild, Symtuza, Truvada, and Viread (the "Settlement"). for the side effects caused by Truvada and their other HIV treatment drugs. The settlement follows a victory for Gilead in a 2023 jury trial on the government’s patent infringement allegations. Mar 4, 2025 · Weeks after settling a five-year patent dispute with the U. Gilead violated federal and state law by illegally providing Jun 16, 2025 · Pharmaceutical manufacturer Gilead Sciences, Inc. Jan 19, 2024 · Gilead Sciences Inc. Apr 29, 2025 · In an announcement Tuesday, the U. The lawsuits allege Gilead failed to warn users about serious health risks. Mar 4, 2024 · The expected average Truvada lawsuit settlement depends on factors like each plaintiff’s damages and the evidence against the drugmaker. Cal. Jul 16, 2025 · Chicago – Attorney General Kwame Raoul, as part of a bipartisan coalition of 49 attorneys general, announced a $202 million multistate settlement agreement with Gilead Sciences Inc. Jan 16, 2025 · Gilead Sciences Inc. 3:19-cv-02573-EMC (N. (Gilead), for running an illegal kickback scheme to promote its HIV medications. If you are one of those patients with a case on file, the bad news is that you might end up waiting a long time for the compensation you are owed. Nov 17, 2025 · HIV DRUGS LAWSUITS Did you suffer kidney injuries or bone fractures on Truvada or other TDF-based HIV drugs? Gilead HIV drugs Truvada, Atripla, Stribild, Viread and Complera have been linked to What Are the Expected Truvada Lawsuit Settlement Amounts When getting into the nitty-gritty of Truvada lawsuits, there’s a lot to keep in mind. and the federal government settled a patent-infringement case in which the US sought $1 billion from the bioscience giant for allegedly using joint research to develop an HIV-prevention drug regimen without compensation. | Authorities say Gilead paid Jan 16, 2025 · Gilead has settled with the U. Sep 14, 2025 · Update on Truvada lawsuit (and Viread). 75 million to end allegations that anticompetitive conduct forced direct purchasers to pay more for drugs used to treat and prevent HIV. The class action lawsuit claims that Gilead Sciences, Inc. and the remainder will be paid to various states. The two companies already settled part of the case in May. You’ve got to get the basics of Truvada lawsuit overview and what’s being said about Gilead Sciences. On June 11, 2024, Gilead Sciences agreed to a $40 Million Truvada settlement, resolving around 2,600 claims by patients who allege to have developed kidney and bone diseases while taking the drug. At issue was Gilead’s HIV speaker program, where Gilead would invite healthcare providers who were involved in […] Feb 12, 2025 · The settlement in U. government reached a settlement last week in a long-running lawsuit over the patents for Truvada and Descovy as pre-exposure prophylaxis (PrEP) to prevent HIV. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. Apr 29, 2025 · The US Attorney for the Southern District of New York announced a $202m settlement with Gilead Sciences, resolving claims the pharmaceutical manufacturer offered and paid kickbacks to doctors who spoke at events to induce them to prescribe the company’s drugs. Truvada lawsuits also claim that Gilead withheld a safer alternative to maximize profits from Truvada. Tenofovir Lawsuit News Gilead tries—and fails—to dodge lawsuit claiming it delayed safer HIV meds Dec 23, 2024 · TDF Litigation The TDF litigation against Gilead Sciences represents a complex intersection of pharmaceutical innovation, corporate responsibility, and patient rights. R. Gilead offered a $40 million settlement in June 2024. As part of the settlement, GILEAD also made extensive factual admissions regarding its conduct. Plaintiffs claim that Gilead failed to adequately warn about the risks of kidney damage and bone density loss associated with the drug, despite the availability of safer alternatives. won final approval Friday to pay $246. Jun 12, 2024 · Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat Apr 29, 2025 · Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying kickbacks to doctors who agreed to prescribe its HIV drugs. Gilead manufacturers and markets pharmaceutical products, including Letairis, which is approved to treat pulmonary arterial hypertension ("PAH"). Sep 12, 2025 · While Gilead Sciences previously ponied up hundreds of millions of dollars to resolve kickback allegations related to its HIV business, the company this week triumphed over a whistleblower lawsuit Jul 17, 2025 · Attorney General Dave Sunday announced that Pennsylvania will receive over $1 million as part of a $202 million multistate settlement with Gilead Sciences, Inc. S. Apr 29, 2025 · The settlement, which calls for Gilead to pay the U. An Indiana man, so protective of his confidentiality that he fills his HIV-related prescriptions at a different Jan 16, 2025 · Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy. Department of Justice (United States Attorney’s Office, Southern District of New York) announced that pharmaceutical giant Gilead Sciences agreed to pay a whopping $202 Million to resolve a False Claims Act investigation. claims that Truvada users were unknowingly put at risk of a number of injuries including kidney injuries and bone injuries. Apr 30, 2025 · On April 29, 2025, the U. Apr 29, 2025 · Gilead entered into this agreement to avoid the cost and distraction of potential litigation regarding this legacy compliance matter. This lawsuit has the potential to rival the OxyContin scandal should the payout eventuate. Attorney Ben Crump has set his sights on these settlements and stands ready to fight for compensation on behalf of people who suffered injuries after taking Truvada HIV medication. According to the settlement papers May 6, 2022 · Gilead Sciences has closed the books on its multimillion-dollar HIV PrEP fraud | The "Kingpin" defendants, who Gilead sued over a scheme to defraud the company's access program, settled for May 21, 2019 · A Gilead Viread lawsuit has largely survived a dismissal motion in federal court, although some of its claims were trimmed. , is ongoing, and no financial settlement has been reached.